Correlation Between Processa Pharmaceuticals and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Processa Pharmaceuticals and AN2 Therapeutics, you can compare the effects of market volatilities on Processa Pharmaceuticals and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and AN2 Therapeutics.
Diversification Opportunities for Processa Pharmaceuticals and AN2 Therapeutics
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Processa and AN2 is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Processa Pharmaceuticals and AN2 Therapeutics
Given the investment horizon of 90 days Processa Pharmaceuticals is expected to generate 1.63 times more return on investment than AN2 Therapeutics. However, Processa Pharmaceuticals is 1.63 times more volatile than AN2 Therapeutics. It trades about -0.02 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 1,640 in Processa Pharmaceuticals on November 5, 2024 and sell it today you would lose (1,575) from holding Processa Pharmaceuticals or give up 96.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Processa Pharmaceuticals vs. AN2 Therapeutics
Performance |
| Timeline |
| Processa Pharmaceuticals |
| AN2 Therapeutics |
Processa Pharmaceuticals and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Processa Pharmaceuticals and AN2 Therapeutics
The main advantage of trading using opposite Processa Pharmaceuticals and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |